Founded in 2010, Internis is a UK speciality pharmaceutical company engaged in the development and commercialisation of highly effective and innovative medicines currently aimed at the treatment and prevention of a range of common bone disorders, such as osteoporosis and vitamin D3 deficiency.
Internis has grown rapidly in the past 4 years since commercialising their first product Accrete-D3. It is positioned now as one of the UK’s fastest growing pharmaceutical companies and is still expanding, by focusing on niche branded products where there is an unmet medical need.
Internis recognises the important work of the National Osteoporosis Society and is committed to supporting them through the Bone Health Partnership.
At Consilient Health we are passionate about developing and supplying prescription medicines that provide benefits to Patients and Prescribers and the NHS. This is achieved through building strong partnerships with our manufacturing, distribution and pharmacy partners. We offer one of the widest ranges of oral contraceptives in the UK, offering high quality products and significant savings for the NHS, complemented by comprehensive support programmes for both medical professionals and patients. We launched our first Bone Health product in 2014 having identified an unmet need for prescribers and patients to have access to licenced medicines within the vitamin D therapeutic area.
Kyowa Kirin Ltd is a specialty pharmaceutical company engaged in the development and commercialisation of prescription medicines for the treatment of unmet therapeutic needs in major markets. Headquartered in Galashiels, Scotland, it is a subsidiary of Kyowa Hakko Kirin Co., Ltd., the Japan-based global specialty pharmaceutical company. Sales and marketing of its portfolio of products are handled by commercial subsidiaries in the UK, US, France, Germany, Spain, Italyand other EU countries.
We are a Medical Technologies Solutions Provider offering software and services that help identify patients requiring medically necessary care.
Through our ASPIRE case finding service, we optimize Fracture Liaison Services (FLS) through opportunistic identification of vertebral fracture patients with osteoporosis. Anonymized patient images, acquired to investigate other conditions, are securely transferred to Optasia for rapid machine learning analysis and over read by a radiologist. Identified fracture patients are reported back to the FLS for investigation and management.
We also provide solutions to the clinical trials and research sectors for accurate and precise anatomical measurements related to disease state.
Rosemont are leading specialists for oral medicines for people who have difficulty swallowing solid medication. Part of Perrigo Company Plc, we have 49 years’ experience of R&D, manufacturing and marketing of liquid alternatives and an extensive range of over 160 formulations. Rosemont is “the source of liquid solutions”.
Twenty-five Harley Street is a day clinic for women. Our philosophy is to provide a uniquely enriching approach to health care. Exceptional health and wellbeing depend on a myriad of elements coming together. With this in mind, we have created a new clinic for women to provide perfectly integrated care and treatment in the areas of gynaecology, aesthetics, dermatology and bone health. In addition, there are experts on hand to help with emotional wellbeing and nutrition. Twenty-five Harley Street day clinic also offers a GP service open to individuals and families. The service we offer is seamless. Our specialists are leaders in their fields.